Writing and composing, hosting award ceremonies, and starring in hit reality TV shows — Kim Sejeong has been there, done that.

The two-part Phase 1/2 trial — dubbed BeCoMe-9 (NCT06611436) — was designed to assess the safety and clinical activity of a ...